NCT00002217View on ClinicalTrials.gov

A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Lamivudine/Zidovudine

DRUG

Abacavir sulfate

DRUG

Amprenavir

Trial Locations (1)

15213

Anderson Clinical Research, Pittsburgh

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002217 - A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs | Biotech Hunter | Biotech Hunter